Articles citing this article

The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).

Cited article:

Signalement d'événements indésirables par les patients : étude pilote réalisée avec la collaboration d'associations de patients

Daphney Nasrallah-Irles, Anne Castot, Laure Thomas, Samy Babai, Bernard Delorme, Hervé Le-Louët

Thérapie, 63 5 (2008) 385-392

Published online: 2009-01-21

DOI: https://doi.org/10.2515/therapie:2008060

This article has been cited by the following article(s):

The Role of European Patient Organizations in Pharmacovigilance

Cristiano Matos, Gerda Weits and Florence van Hunsel
Drug Safety 42 (4) 547 (2019)
https://doi.org/10.1007/s40264-018-0748-x

Informativeness of patient initial reports of adverse drug reactions. Can it be improved by a pharmacovigilance centre?

F Kheloufi, A Default, F Rouby, et al.
European Journal of Clinical Pharmacology 73 (8) 1009 (2017)
https://doi.org/10.1007/s00228-017-2254-y

Comment on “Patient Reporting in the EU: Analysis of EudraVigilance Data”

Farid Kheloufi, Anne Default, Frank Rouby, Olivier Blin and Joelle Micallef
Drug Safety 40 (10) 935 (2017)
https://doi.org/10.1007/s40264-017-0568-4

Mesure de la culture sécurité des soins auprès des médecins dans un hôpital tunisien

Nabiha Bouafia, Mohamed Mahjoub, Asma Ben Cheikh, Olfa Ezzi, Naceur Ben Jalleb and Mansour Njah
Santé Publique Vol. 26 (3) 345 (2014)
https://doi.org/10.3917/spub.139.0345

First French Experience of ADR Reporting by Patients After a Mass Immunization Campaign with Influenza A (H1N1) Pandemic Vaccines

Geneviève Durrieu, Aurore Palmaro, Laure Pourcel, et al.
Drug Safety 35 (10) 845 (2012)
https://doi.org/10.2165/11631800-000000000-00000

First French Experience of ADR Reporting by Patients After a Mass Immunization Campaign with Influenza A (H1N1) Pandemic Vaccines

Geneviéve Durrieu, Aurore Palmaro, Laure Pourcel, Céline Caillet, Angeline Faucher, Alexis Jacquet, Shéhérazade Ouaret, Marie Christine Perault-Pochat, Carmen Kreft-Jais, Anne Castot, Maryse Lapeyre-Mestre and Jean-Louis Montastruc
Drug Safety 35 (10) 845 (2012)
https://doi.org/10.1007/BF03261980

Le point sur quelques décisions récentes en matière de pharmacovigilance pour la pratique officinale

Jacques Buxeraud
Actualités Pharmaceutiques 50 (508) 32 (2011)
https://doi.org/10.1016/S0515-3700(11)71022-9

Bilan du suivi de PharmacoVigilance des vaccins contre la grippe A(H1N1)v durant la campagne 2009-2010 en France

Jean-Louis Montastruc, E Autret-Leca, B Baldin B, F Bavoux, A Bénard-Laribière, M Biour, MN Beyens, F Colin, A Cocquerel, S Crepin, G Décréau-Gaillon, S Dos Santos, P Eftekhari, S Favrelière, S Gautier, V Gras-Champel, L Javot, MJ Jean-Pastor, C Le Beller, B Lebrun-Vignes, A Millaret, A Perrazi, V Pinzani, C Riché, E Schir, et al.
Bulletin de l'Académie Nationale de Médecine 195 (6) 1309 (2011)
https://doi.org/10.1016/S0001-4079(19)31991-0